Androgen-signaling inhibitors extend survival in luminal mCRPC subtypeOctober 20, 2021Prostate Cancer
Metastatic prostate cancer: EBRT has no survival benefit in newly diagnosed elderlyOctober 20, 2021Prostate Cancer
Localized prostate cancer: Robot-assisted laparoscopic prostatectomy safe in long termOctober 20, 2021Prostate Cancer
Recurrent prostate cancer: Adding abiraterone-prednisone delays PSA progressionOctober 20, 2021Prostate Cancer
Prostate cancer: 68Ga-PSMA-11 PET scan may miss pelvic nodal metastasisOctober 20, 2021Prostate Cancer
Prostate cancer: 68Ga-PSMA-11 PET scan may miss pelvic nodal metastasisOctober 20, 2021Prostate Cancer
Metastatic prostate cancer: Abiraterone tied to worse cardiovascular outcomesSeptember 18, 2021Prostate Cancer
High-risk prostate cancer: Persistent PSA after surgery linked to worse outcomesSeptember 18, 2021Prostate Cancer
Prostate cancer: Exercise during active surveillance improves cardiorespiratory fitnessSeptember 18, 2021Prostate Cancer
MRI with PSMA-PET lowers false negatives for clinically significant prostate cancerSeptember 18, 2021Prostate Cancer
Avelumab with SBRT shows good response in castration-resistant prostate cancerSeptember 18, 2021Prostate Cancer
Prostate cancer: Cardiovascular safety of hormone therapies remains unresolvedSeptember 18, 2021Prostate Cancer
